These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Overview of recent clinical and methodological advances from clinical trials of cardiovascular disease. Friedewald WT; Schoenberger JA Control Clin Trials; 1982 Sep; 3(3):259-70. PubMed ID: 6129942 [TBL] [Abstract][Full Text] [Related]
28. Sulphinpyrazone (Anturan) after myocardial infarct. Watt M N Z Med J; 1979 Oct; 90(646):352. PubMed ID: 392352 [No Abstract] [Full Text] [Related]
29. FDA says no to anturane. Kolata GB Science; 1980 Jun; 208(4448):1130-2. PubMed ID: 6990491 [No Abstract] [Full Text] [Related]
30. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct]. Foz M Med Clin (Barc); 1980 Jun; 75(1):32-4. PubMed ID: 7392709 [No Abstract] [Full Text] [Related]
31. In vivo platelet hyperactivity and factor VIII related antigen increase long after myocardial infarction. A controlled effect of sulfinpyrazone. Cortellaro M; Boschetti C; Beggi P; Polli EE Scand J Haematol; 1981 Feb; 26(2):106-14. PubMed ID: 6454960 [TBL] [Abstract][Full Text] [Related]
32. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction. S Afr Med J; 1980 Mar; 57(9):301-2. PubMed ID: 6986664 [No Abstract] [Full Text] [Related]
33. The anturane reinfarction trial. Sauerbruch T; Kaess H N Engl J Med; 1980 Jul; 303(1):49-50. PubMed ID: 6990266 [No Abstract] [Full Text] [Related]
37. Cardiac death prevention in post-myocardial infarction patients: a review. Boissel JP; Leizorovicz A; Faucomprez C Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625 [No Abstract] [Full Text] [Related]
38. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct]. Rühle H Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541 [No Abstract] [Full Text] [Related]
39. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery. Cairns JA Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983 [No Abstract] [Full Text] [Related]
40. On the limitation of therapeutic intervention trials in ischemic heart disease: a clinician's viewpoint. Selzer A Am J Cardiol; 1982 Jan; 49(1):252-5. PubMed ID: 6976116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]